The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Open accessAbstract
Histone acetylation plays important roles in gene regulation, DNA replication, and the response to DNA damage, and it is frequently deregulated in tumors. We postulated that tumor cell histone acetylation levels are determined in part by changes in acetyl coenzyme A (acetyl-CoA) availability mediated by oncogenic metabolic reprogramming. Here, we demonstrate that acetyl-CoA is dynamically regulated by glucose availability in cancer cells and that the ratio of acetyl-CoA:coenzyme A within the nucleus modulates global histone acetylation levels. In vivo, expression of oncogenic Kras or Akt stimulates histone acetylation changes that precede tumor development. Furthermore, we show that Akt's effects on histone acetylation are mediated through the metabolic enzyme ATP-citrate lyase and that pAkt(Ser473) levels correlate significantly with histone acetylation marks in human gliomas and prostate tumors. The data implicate acetyl-CoA metabolism as a key determinant of histone acetylation levels in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, citrate export to the cytosol and subsequent cleavage by ACL provides a major source of cytosolic acetyl-CoA that is the obligate substrate for both de novo lipid synthesis and protein acetylation reactions (39, 187, 188).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [188]
In the citing paper
“Accordingly, oncogenic activation of the PI3K–AKT signaling axis increases acetyl-CoA levels and promotes elevated histone acetylation both in vitro and in tumors (188).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [188]
In the citing paper
“Immunohistochemical analysis of glioblastoma and prostate tumor samples has shown that Akt activation levels closely correlate with global histone acetylation status (Lee et al., 2014).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“Furthermore, studies have shown that both the glucose- and oncogene-driven increases in global histone acetylation are blocked by ACLY inhibition (Lee et al., 2014; Wellen et al., 2009).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“Indeed, withdrawal and readdition of glucose, as well as activation of oncogenic signaling via introduction of an oncogenic KRAS mutant or a constitutively active form of Akt, increase total histone acetylation, which, in turn, promotes the enhanced and broader gene expression (Lee et al., 2014).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“The effect of itaconate on ROS production is consistent with a previous study in zebrafish macrophages, which demonstrated that IRG1 was essential for OXPHOS-driven mtROS production and bactericidal killing172.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Self-citationEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 562
Hsp90 as a “Chaperone” of the Epigenome
Isaacs, J. S. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.09.003 · Cited by 28
Acetyl-CoA-directed gene transcription in cancer cellsPreprint
Martínez‐Reyes, I., & Chandel, N. S. (2018) · Genes & Development · doi:10.1101/gad.315168.118 · Cited by 27
Huang, G. J., Li, Z., Liu, X., Guan, M., Zhou, S., Zhong, X., Zheng, T., Xin, D. E., Gu, X., Mu, D., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01754-9 · Cited by 29
Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review
Masui, K., Harachi, M., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2020) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.20002 · Cited by 24
Gopal, U., & Pizzo, S. V. (2017) · Oncotarget · doi:10.18632/oncotarget.22431 · Cited by 28
p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations
Oikawa, T., Otsuka, Y., & Sabe, H. (2018) · Cancers · doi:10.3390/cancers10060162 · Cited by 24
Acetate regulates GAPDH acetylation and T helper 1 cell differentiation
Jing, X., Lyu, J., & Xiong, J. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-02-0070 · Cited by 28
Metabolic Intermediates in Tumorigenesis and Progression
He, Y., Gao, M., Tang, H., Cao, Y., Liu, S., & Tao, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33496 · Cited by 25
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04995-1 · Cited by 26
Zhao, H., Zhong, S., Sang, L., Zhang, X., Chen, Z., Wei’s, Q., Chen, G., Liu, J., & Yu, Y. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa208 · Cited by 24
Mitochondria as a Platform for Dictating the Cell Fate of Cultured Human Corneal Endothelial Cells
Numa, K., Ueno, M., Fujita, T., Ueda, K., Hiramoto, N., Mukai, A., Tokuda, Y., Nakano, M., Sotozono, C., Kinoshita, S., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.10 · Cited by 24
Corroyer‐Dulmont, A., Valable, S., Fantin, J., Châtre, L., Toutain, J., Teulier, S., Bazille, C., Letissier, E., Levallet, J., Divoux, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90662-0 · Cited by 24
Inaba, J.-I., McConnell, E. J., & Davis, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223705 · Cited by 24
Sanna, P. P., Fu, Y., Masliah, E., Lefèbvre, C., & Repunte‐Canonigo, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-88052-7 · Cited by 23
Sorokin, A., Shurkhay, V. A., Игоревич, П. С., Zhvansky, E. S., Ivanov, D. G., Kulikov, E. E., Popov, I. A., Aa, P., & Николаев, Е. Н. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190729154543 · Cited by 24
Zhang, J., Duan, H., Feng, Z., Han, X., & Gu, C. (2020) · Oncogenesis · doi:10.1038/s41389-020-0230-3 · Cited by 23
RetractedRole of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
Guerra, B., & Issinger, O. (2020) · Pharmaceuticals · doi:10.3390/ph13100292 · Cited by 25
Penugurti, V., Khumukcham, S. S., Padala, C., Dwivedi, A., Reddy, K. R. K., Srinivasulu, M., Bhopal, T., & Manavathi, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.027 · Cited by 23
Tumor-suppressive function of EZH2 is through inhibiting glutaminase
Liu, Y., Tu, C., Guo, X., Wu, C., Gu, C.-C., Lai, Q., Fang, Y., Huang, J., Wang, Z., Li, A., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04212-7 · Cited by 22
Connections between metabolism and epigenetic modifications in cancer
Wang, G., & Han, J. J. (2021) · Medical Review · doi:10.1515/mr-2021-0015 · Cited by 27
The dual role of citrate in cancer
Icard, P., Simula, L., Zahn, G., Alifano, M., & Mycielska, M. E. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188987 · Cited by 25
Berghoff, B. A., Karlsson, T., Källman, T., Wagner, E. G. H., & Grabherr, M. G. (2017) · BioData Mining · doi:10.1186/s13040-017-0150-8 · Cited by 23
Epigenetic regulation by endogenous metabolite pharmacology
Kulkarni, R. A., Montgomery, D. C., & Meier, J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.002 · Cited by 24
ATP-citrate lyase promotes axonal transport across species
Even, A., Morelli, G., Turchetto, S., Shilian, M., Bail, R. L., Laguesse, S., Krusy, N., Brisker, A., Brandis, A. S., Inbar, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25786-y · Cited by 23
Metformin targets histone acetylation in cancer-prone epithelial cells
Cuyàs, E., Fernández‐Arroyo, S., Joven, J., & Menéndez, J. A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1249547 · Cited by 23
Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
Lyu, S., Gildor, N., Zhang, Q. H., & Liao, C. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2979-3 · Cited by 27
Russo, M., Gualdrini, F., Vallelonga, V., Prosperini, E., Noberini, R., Pedretti, S., Borriero, C., Chiaro, P. D., Polletti, S., Imperato, G., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.033 · Cited by 21
Impact of acetylation on tumor metabolism
Zhao, D., Li, F.-L., Cheng, Z., & Lei, Q. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963452 · Cited by 24
Yu, Y., Moretti, I. F., Grzeschik, N. A., Sibon, O. C. M., & Schepers, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118965 · Cited by 21
Zheng, W., Tasselli, L., Li, T., & Chua, K. F. (2021) · Genes · doi:10.3390/genes12091460 · Cited by 22
Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4
García-Fojeda, B., Minutti, C. M., Montero-Fernández, C., Stamme, C., & Casals, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860262 · Cited by 21
The mechanisms and factors that induce trained immunity in arthropods and mollusks
Zhao, M., Lin, Z., Zheng, Z., Yao, D., Yang, S., Zhao, Y., Chen, X., Aweya, J. J., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1241934 · Cited by 22
Nutrient allocation fuels T cell-mediated immunity
Longo, J., Watson, M. J., Williams, K. S., Sheldon, R. D., & Jones, R. G. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.09.008 · Cited by 19
Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia
Lee, C., Kim, M. G., Park, C., Jo, W., Seo, J. K., Kim, S., Oh, J., Kim, C.-S., Ryu, H. S., Lee, K.-H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36179-8 · Cited by 21
Cytoskeletal association of ATP citrate lyase controls the mechanodynamics of macropinocytosis
Puccini, J., Jia, W., Tong, L., & Bar‐Sagi, D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213272120 · Cited by 20
The pyruvate dehydrogenase complex at the epigenetic crossroads of acetylation and lactylation
Stacpoole, P. W., & Dirain, C. O. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108540 · Cited by 21
Epigenome modifiers and metabolic rewiring: New frontiers in therapeutics
Ferrari, A., Longo, R., Silva, R., Mitro, N., Caruso, D., De Fabiani, E., & Crestani, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.008 · Cited by 19
Nuclear Acly protects the liver from ischemia-reperfusion injury
Gao, W., Zhang, L., Li, Z., Wu, T., Lang, C., Mulholland, M. W., & Zhang, W. (2023) · Hepatology · doi:10.1097/hep.0000000000000692 · Cited by 19
Bioorthogonal pro-metabolites for profiling short chain fatty acylation
Sinclair, W. R., Shrimp, J. H., Zengeya, T. T., Kulkarni, R. A., Garlick, J. M., Luecke, H. F., Worth, A. J., Blair, I. A., Snyder, N. W., & Meier, J. L. (2017) · Chemical Science · doi:10.1039/c7sc00247e · Cited by 19
Sola‐García, A., Cáliz‐Molina, M. Á., Espadas, I., Petr, M. A., Panadero‐Morón, C., González-Morán, D., Martín-Vázquez, M. E., Narbona‐Pérez, Á. J., López–Noriega, L., Martínez-Corrales, G., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04625-4 · Cited by 21
Breakdown and repair of metabolism in the aging brain
Shichkova, P., Coggan, J. S., Kanari, L., Boci, E., Favreau, C., Antonel, S., Keller, D. X., & Markram, H. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1441297 · Cited by 22
Metabolism and chromatin dynamics in health and disease
Rodriguez, H., Rafehi, H., Bhave, M. R., & El‐Osta, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.004 · Cited by 18
Dynamic protein deacetylation is a limited carbon source for acetyl-CoA–dependent metabolism
Soaita, I., Megill, E., Kantner, D. S., Chatoff, A. G., Cheong, Y. J., Clarke, P., Arany, Z. P., Snyder, N. W., Wellen, K. E., & Trefely, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104772 · Cited by 18
Snyder, N. W., Basu, S. S., Worth, A. J., Mesaros, C., & Blair, I. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055384 · Cited by 18
Metabolism fine-tunes macrophage activation
Torres, A., Makowski, L., & Wellen, K. E. (2016) · eLife · doi:10.7554/elife.14354 · Cited by 18
Proteins moonlighting in tumor metabolism and epigenetics
Lv, L., & Lei, Q. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0818-1 · Cited by 18
Indriani, F., Mahmudah, K. R., Purnama, B., & Satou, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.885929 · Cited by 15
Adhikari, S., Guha, D., Mohan, C., Mukherjee, S., Tyler, J. K., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_1 · Cited by 19
The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases
Xie, J., Chen, X., Zheng, M., Zhu, J., & Mao, H. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904143 · Cited by 18
Cooperative Instruction of Signaling and Metabolic Pathways on the Epigenetic Landscape.
Kim, J.-A. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0076 · Cited by 17
From Powerhouse to Perpetrator—Mitochondria in Health and Disease
Fakouri, N. B., Hansen, T. L., Desler, C., Anugula, S., & Rasmussen, L. J. (2019) · Biology · doi:10.3390/biology8020035 · Cited by 19
Super Secondary Structures of Proteins with Post-Translational Modifications in Colon Cancer
Tikhonov, D. A., Kulikova, L. I., Kopylov, A. T., Malsagova, K. A., Stepanov, A. A., Rudnev, V. R., & Kaysheva, A. L. (2020) · Molecules · doi:10.3390/molecules25143144 · Cited by 15
Bhattacharya, S., & Tu, B. P. (2024) · Journal of Cell Science · doi:10.1242/jcs.261250 · Cited by 16
Simão, J. D. J., Bispo, A. F. D. S., Plata, V. T. G., Armelin‐Correa, L., & Alonso‐Vale, M. I. C. (2024) · Pharmaceuticals · doi:10.3390/ph17070861 · Cited by 18
Campit, S., Meliki, A., Youngson, N. A., & Chandrasekaran, S. (2020) · BioEssays · doi:10.1002/bies.202000083 · Cited by 17
The short-chain fatty acid acetate modulates epithelial-to-mesenchymal transition
Lyu, J., Pirooznia, M., Li, Y., & Xiong, J. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-02-0066 · Cited by 16
A chemical catalyst enabling histone acylation with endogenous acyl-CoA
Habazaki, M., Mizumoto, S., Kajino, H., Kujirai, T., Kurumizaka, H., Kawashima, S. A., Yamatsugu, K., & Kanai, M. (2023) · Nature Communications · doi:10.1038/s41467-023-41426-z · Cited by 15
Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors
Crawford, M. C., Tripu, D. R., Barritt, S. A., Jing, Y., Gallimore, D., Kales, S. C., Bhanu, N. V., Xiong, Y., Fang, Y., Butler, K. A. T., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00293 · Cited by 15
Chiang, J., Shang, Z., Rosales, T. I., Cai, L., Chen, W., Cai, F., Vu, H. S., Minna, J. D., Ni, M., Davis, A. J., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt1241 · Cited by 17
Rashad, S., & Marahleh, A. (2025) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70011 · Cited by 14
Masui, K., Shibata, N., Cavenee, W. K., & Mischel, P. S. (2016) · BioEssays · doi:10.1002/bies.201600026 · Cited by 15
Metabolic Vulnerabilities in Multiple Myeloma
Lim, J. S. L., Chong, P. S. Y., & Chng, W. J. (2022) · Cancers · doi:10.3390/cancers14081905 · Cited by 15
Methyl Group Metabolism in Differentiation, Aging, and Cancer
Erichsen, L., Thimm, C., & Santourlidis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158378 · Cited by 15
Murthy, D., & Attri, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087304 · Cited by 14
Potential therapies targeting nuclear metabolic regulation in cancer
Chen, Y., Xu, J., Liu, X., Guo, L., Yi, P., & Cheng, C. (2023) · MedComm · doi:10.1002/mco2.421 · Cited by 14
Histone acetylation: a key determinant of acquired cisplatin resistance in cancer
Natu, A., Verma, T., Khade, B., Thorat, R. A., Gera, P. B., Dhara, S., & Gupta, S. (2024) · Clinical Epigenetics · doi:10.1186/s13148-023-01615-5 · Cited by 17
Liu, J., Wang, Y., Tian, M., Xia, M., Zheng, Y., Hao, M., Qian, Y., Shu, H., Zhang, W., Peng, P., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402674121 · Cited by 15
Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway
da Silva, M. F., Lins, A. A., Gomes, M. C., Marinho, W. P. D. J., de Araújo, R. S. A., de Moura, R. O., Zhan, P., Nascimento, I. J. D. S., & Júnior, E. F. D. S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673325229240928040758 · Cited by 14
Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
Zhang, X., Dong, Z., & Cui, H. (2021) · Biomolecules · doi:10.3390/biom11101406 · Cited by 14
TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression
Sun, S.-J., Ai, Y., Duan, K., Zhang, J., Zhang, C., Sun, Y., Xiong, Y., Guan, K., & Yuan, H. (2022) · Oncogene · doi:10.1038/s41388-022-02531-3 · Cited by 13
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Why and how citrate may sensitize malignant tumors to immunotherapy
Icard, P., Prieto, M., Coquerel, A., Fournel, L., Gligorov, J., Noel, J., Mouren, A., Dohan, A. J. J., Alifano, M., & Simula, L. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101177 · Cited by 14
Singh, R., & Mills, I. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704353 · Cited by 13
He, Y., Wang, S., Liu, S., Qin, D., Liu, Z., Wang, L., Chen, X., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202301094 · Cited by 13
Autoimmune Hepatitis and Stellate Cells: An Insight into the Role of Autophagy
Golbabapour, S., Lankarani, K. B., Ghavami, S., & Geramizadeh, B. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190402120231 · Cited by 13
Ordway, B., Swietach, P., Gillies, R. J., & Damaghi, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00373 · Cited by 13
TCA-cycle metabolites in the nucleus: drivers of chromatin and epigenetic control
Ghisletti, S., & Russo, M. (2025) · BMC Biology · doi:10.1186/s12915-025-02423-4 · Cited by 12
AKT regulates hemocyte proliferation via glucose metabolism in Eriocheir sinensis
Wang, Y., Nan, X., Hao, S., Zhao, K., Guo, Y., Wang, Q., & Li, W. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.06.025 · Cited by 12
Xi, C., Pang, J., Barrett, A., Horuzsko, A., Ande, S., Mivechi, N. F., & Zhu, X. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0935 · Cited by 12
A feedforward loop between ACLY and MYC supports T-ALL progression in vivo
da Silva-Diz, V., Singh, A., Aleksandrova, M., Kim, O., Thai, C., Lancho, O., Nunes, P. R., Affronti, H. C., de Paz, A. M., Josefowicz, S. Z., et al. (2025) · Blood Neoplasia · doi:10.1016/j.bneo.2025.100069 · Cited by 12
Research advances on epigenetics and cancer metabolism
Han, H., Feng, F., & Li, H. (2021) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0053 · Cited by 12
Ran, R., Zhong, X., Yang, Y., Tang, X., Shi, M., Jiang, X., Lin, A., Gan, X., Yu, T., Hu, L., et al. (2023) · Medical Oncology · doi:10.1007/s12032-022-01848-z · Cited by 12
Rotenone Stereospecifically Increases (S)-2-Hydroxyglutarate in SH-SY5Y Neuronal Cells
Worth, A. J., Gillespie, K. P., Mesaros, C., Guo, L., Basu, S. S., Snyder, N. W., & Blair, I. A. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500535c · Cited by 12
Latorre‐Muro, P., Baeza, J., Hurtado‐Guerrero, R., Hicks, T., Delso, I., Hernández-Ruiz, C., Velázquez‐Campoy, A., Lawton, A. J., Angulo, J., Denu, J. M., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015103 · Cited by 13
Chen, W., Liao, K., Chen, H., Xiao, Z.-X., Meng, Q., Liu, Z., Lu, Y., Sheng, H., Mo, H., Wu, Q.-N., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02221-y · Cited by 13
Calorie restriction mimetics against aging and inflammation
Chaudhary, S., Chaudhary, M. R., Jena, M. K., Rath, P. K., Mishra, B. P., Paital, B., Vyas, A., Sahoo, D. K., Singh, P., & Mehdi, M. M. (2025) · Biogerontology · doi:10.1007/s10522-025-10269-0 · Cited by 13
Dominguez, M., Trümper, V., Mota, A. C., Brüne, B., & Namgaladze, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906127 · Cited by 15
Abraki, S. B., Karamali, F., & Nasr‐Esfahani, M. H. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10338-8 · Cited by 11
Fang, L., Qi, H., Wang, P., Wang, S., Li, T., Xia, T., Piao, H., & Gu, C. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200144 · Cited by 11
Iqbal, M. A., Siddiqui, S., Smith, K., Singh, P. K., Kumar, B., Chouaı̈b, S., & Chandrasekaran, S. (2023) · iScience · doi:10.1016/j.isci.2023.108059 · Cited by 13
The Crucial Roles of Intermediate Metabolites in Cancer
Huang, S., Wang, Z., & Zhao, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s321433 · Cited by 11
Growth Signaling Networks Orchestrate Cancer Metabolic NetworksPreprint
Manning, B. D., & Dibble, C. C. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041543 · Cited by 11
Wang, Z., Dai, R., Li, K., Yang, H., Chen, Z., He, J., Shu, L., Zhong, Y., Zhang, Y., Hua, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63591-z · Cited by 10
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Natarajan, S. K., Pun, M. J., Haggerty-Skeans, J., & Venneti, S. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023424 · Cited by 13
Bandopadhyay, S., Kamal, I. M., Padmanaban, E., Ghosh, D. D., Chakrabarti, S., & Roy, S. S. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30381 · Cited by 10
PTPN2 Regulates Metabolic Flux to Affect β-Cell Susceptibility to Inflammatory Stress
Kim, Y. K., Kim, Y. R., Wells, K. L., Sarbaugh, D., Guney, M. A., Tsai, C., Zee, T., Karsenty, G., Nakayasu, E. S., & Sussel, L. (2023) · Diabetes · doi:10.2337/db23-0355 · Cited by 10
Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancer
Zheng, X., Zhang, S., Ma, H., Dong, Y., Zheng, J., Zeng, L., Liu, J., Dai, Y., & Yin, Q. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112321 · Cited by 10
KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation
Budagyan, K., Cannon, A. C., Chatoff, A. G., Benton, D., Kurimchak, A., Araiza‐Olivera, D., Gerasimova, A., Snyder, N. W., Duncan, J. S., Uribe‐Alvarez, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115444 · Cited by 11
Espitia-Pérez, P., Espitia-Pérez, L., & Negrette-Guzmán, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136013 · Cited by 10
The role and regulatory mechanisms of the TCA cycle in early embryonic development
Lai, Y., Gao, X., Zhao, L., Liu, J., Gao, C., Yan, Q., Zeng, Y., Liao, Z., & Zhong, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1662431 · Cited by 11
Metadata
- Authors
- Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., Jackson, E., Aiello, N. M., Haas, N. B., Rebbeck, T. R., Judkins, A., Won, K.-J., Chodosh, L. A., Garcia, B. A., Stanger, B. Z., Feldman, M. D., Blair, I. A., & Wellen, K. E.
- Affiliations
- Abramson Cancer Center (US)
- University of Pennsylvania (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Southern California (US)
- Corresponding author
- Wellen, Kathryn E.
- ORCID
- Lee, Joyce V.
- Carrer, Alessandro
- Snyder, Nathaniel W.
- Wei, Shuanzeng
- Venneti, Sriram
- Yuan, Zuo-Fei
- Lim, Hee-Woong
- Liu, Shichong
- Aiello, Nicole M.
- Haas, Naomi B.
- Rebbeck, Timothy R.
- Judkins, Alexander
- Won, Kyoung-Jae
- Chodosh, Lewis A.
- Garcia, Benjamin A.
- Stanger, Ben Z.
- Feldman, Michael D.
- Blair, Ian A.
- Wellen, Kathryn E.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 20
- Issue
- 2
- Pages
- 306-319
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4151270
- OpenAlex
- W2022222857
- Cited by
- 563
- References
- 56
- Citations by year
- 2026: 23 · 2025: 40 · 2024: 51 · 2023: 56 · 2022: 48 · 2021: 68 · 2020: 62 · 2019: 54 · 2018: 41 · 2017: 38 · 2016: 39 · 2015: 30 · 2014: 10
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Pew Charitable Trusts
- National Institutes of Health (DP2OD007447)
- National Cancer Institute (R01CA174761, K08CA181475, P30CA016520)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK098769, P30 DK 19525, P30DK019525)
- National Institute of Environmental Health Sciences (P30ES0138328, T32ES019851, P30ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- histone acetylation, acetyl-CoA, metabolic reprogramming, Akt signaling, KRAS, ATP citrate lyase, glucose availability, coenzyme A, glioma, prostate cancer, cancer metabolism, epigenetic regulation
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Brain Neoplasms, Coenzyme A, Glioma, Glucose, Histones, Humans, Interleukin-3, Male, Phosphorylation, Prostatic Neoplasms, Cluster Analysis, ras Proteins, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
